Platinum ineligibility in squamous cell carcinoma of the head and neck: consensus from Central America and the Caribbean

被引：1

作者：

Alvarado-Munoz, Juan F. ^{[1
]}

Falco, Agustin ^{[2
]}

Morales, Agatha R. ^{[1
]}

Sanchez, Noe C. ^{[3
]}

Reynoso, Giovanni ^{[3
]}

Barillas, Allan ^{[3
]}

Moreno, Jairo ^{[4
]}

Lopez, Kreilin ^{[5
]}

Prestol, Rogelio ^{[5
]}

Cabreja, Angela ^{[6
]}

Nunez, Cesar ^{[6
]}

机构：

[1] Roosevelt Hosp, Guatemala City, Guatemala

[2] Alexander Fleming Inst Oncol, Buenos Aires, DF, Argentina

[3] Guatemalan Social Secur Inst, Guatemala City, Guatemala

[4] Natl Police Hosp, Managua, Nicaragua

[5] Heriberto Pieter Canc Inst, Santo Domingo, Dominican Rep

[6] Reg Oncol Inst Cibao, Santiago Los Caballeros, Dominican Rep

来源：

FUTURE ONCOLOGY | 2021年 / 17卷 / 15期

关键词：

cetuximab; Cisplatin; head and neck cancer; platinum toxicity; LOCALLY ADVANCED HEAD; CISPLATIN-INDUCED NEPHROTOXICITY; QUALITY-OF-LIFE; WEIGHT-LOSS; ELDERLY-PATIENTS; AIR-POLLUTION; HEARING-LOSS; LUNG-CANCER; RADIOTHERAPY; CONCURRENT;

D O I：

10.2217/fon-2020-0931

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The high incidence of head and neck cancer in Central America and the Caribbean, together with limitations in the healthcare system for patients with locally advanced squamous cell carcinoma of the head and neck (LA SCCHN) in this region necessitate a consensus of opinion based on a review of the literature on therapy with cisplatin plus radiation. Such an approach will ensure appropriate selection of patients who can benefit from therapy and reduce the incidence of related adverse events. Therefore, we recorded the opinion of experts in the region in order to identify needs and challenges in the treatment of LA SCCHN.

引用

页码：1963 / 1971

页数：9

共 50 条

[1] Cetuximab in the treatment of squamous cell carcinoma of the head and neck
Specenier, Pol
Vermorken, Jan B.
EXPERT REVIEW OF ANTICANCER THERAPY, 2011, 11 (04) : 511 - 524
[2] Platinum rechallenge in recurrent head and neck squamous cell carcinoma after primary chemoradiation
Rambeau, A.
Licaj, I
Gery, B.
Gervais, R.
Florescu, C.
Babin, E.
De Raucourt, D.
Johnson, A.
Thariat, J.
EUROPEAN ANNALS OF OTORHINOLARYNGOLOGY-HEAD AND NECK DISEASES, 2019, 136 (04) : 257 - 261
[3] Treatment of elderly Patients with Squamous Cell Carcinoma of the Head and Neck
Szturz, Petr
Vermorken, Jan B.
FRONTIERS IN ONCOLOGY, 2016, 6
[4] Immunotherapy for squamous cell carcinoma of the head and neck - experience from Slovenia
Plavc, Gaber
Strojan, Primoz
Azarija, Jelena
Kuhar, Cvetka Grasic
ONKOLOGIJA, 2021, 25 (01) : 6 - 11
[5] Head and neck squamous cell carcinoma
Johnson, Daniel E.
Burtness, Barbara
Leemans, C. Rene
Lui, Vivian Wai Yan
Bauman, Julie E.
Grandis, Jennifer R.
NATURE REVIEWS DISEASE PRIMERS, 2020, 6 (01):
[6] The impact of cumulative dose of cisplatin on outcome of patients with head and neck squamous cell carcinoma
Al-Mamgani, A.
de Ridder, M.
Navran, A.
Klop, W. M.
de Boer, J. P.
Tesselaar, M. E.
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2017, 274 (10) : 3757 - 3765
[7] Platinum resistance and sensitivity in recurrent/metastatic head and neck squamous cell carcinoma
Horichi, Yuto
Matsui, Hidetoshi
Yamamura, Yuta
Iwae, Shigemichi
AURIS NASUS LARYNX, 2024, 51 (01) : 132 - 137
[8] Ibero-American Expert Consensus on Squamous Cell Carcinoma of the Head and Neck Treatment in Patients Unable to Receive Cisplatin: Recommendations for Clinical Practice
Falco, Agustin
de Oliveira, Thiago Bueno
Cacicedo, Jon
Ospina, Aylen Vanessa
Ticona, Miguel Angel
Galindo, Hector
Pereira, Marcos David
Aguilar-Ponce, Jose Luis
Rueda-Dominguez, Antonio
Soria, Tannia
Taberna, Miren
Iglesias, Lara
Sowley, Taysser
Mesia, Ricard
CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 6689 - 6703
[9] Advanced Squamous Cell Carcinoma of the Head and Neck: The Current Role of Cetuximab
Granados-Garcia, Martin
Luis Aguilar-Ponce, Jose
Maldonado-Magos, Federico
De la Garza-Salazar, Jaime G.
ORL-JOURNAL FOR OTO-RHINO-LARYNGOLOGY HEAD AND NECK SURGERY, 2016, 78 (06): : 320 - 333
[10] Induction chemotherapy in squamous cell carcinoma of the head and neck: Saved by the bell?
Specenier, Pol
ORAL ONCOLOGY, 2015, 51 (02) : E5 - E7

← 1 2 3 4 5 →